AMAG Pharmaceuticals Announces 2016 Analyst Day

WALTHAM, Mass., May 19, 2016 (GLOBE NEWSWIRE) — AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG), a specialty pharmaceutical company with a diverse portfolio of products in the areas of maternal health, anemia management and cancer supportive care, today announced that it will host an Analyst Day in New York City on Wednesday, June 1, 2016. The event will start at 8:30 a.m. and conclude at approximately 12:00 p.m. ET.

In-person attendance requires advanced registration. Please email to register or for further information. A live webcast of the event will be available in the investor relations section of AMAG Pharmaceuticals’ website at A replay of the webcast will be available on the website for 30 days after the conclusion of the event.

About AMAG
AMAG is a biopharmaceutical company focused on bringing therapeutics to market that provide clear benefits and help improve people’s lives. Headquartered in Waltham, MA, AMAG possesses a diverse portfolio of products to support the health of patients in the areas of maternal health, anemia management and cancer supportive care. Through CBR®, the company also helps families to preserve newborn stem cells, which are used today in transplant medicine for certain cancers and blood, immune and metabolic disorders, and have the potential to play a valuable role in the ongoing development of regenerative medicine. For additional company information, please visit

AMAG Pharmaceuticals® is a registered trademark of AMAG Pharmaceuticals, Inc. and CBR® is a registered trademark of CBR Systems, Inc.

AMAG Pharmaceuticals, Inc.
Linda Lennox
Vice President, Investor Relations

Primary Logo

AMAG Pharmaceuticals, Inc.